Carroz Karina Portillo, Urrutia-Royo Blanca, Marin Antonio, Pons Laura Rodriguez, Millán-Billi Paloma, Rosell Antoni, Moran-Mendoza Onofre
Pulmonology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.
J Thorac Dis. 2024 Sep 30;16(9):6320-6338. doi: 10.21037/jtd-24-450. Epub 2024 Sep 26.
Interstitial lung diseases (ILDs) encompass over 200 entities. Among them, fibrosing lung diseases, have recently generated special interest due to the emerging therapies for their management. However, it is important to deepen our knowledge of other less prevalent ILD, since many of them are associated with a poor prognosis. This narrative review aims to provide a practical and up-to-date description of some poorly recognized ILD. It covers rare idiopathic interstitial pneumonias and their histologic patterns, genetic disorders with interstitial lung involvement (Hermansky-Pudlak syndrome), and ILD associated with benign proliferation of pulmonary lymphoid tissue, namely follicular bronchiolitis and granulomatous-lymphocytic interstitial lung disease.
Electronic searches of PubMed and Google Scholar using specific keywords were conducted. Articles underwent screening for relevance, covering review articles, meta-analyses, systematic reviews, case series, prospective studies, society guidelines, editorials in peer-reviewed journals; scientific books on the subject. The data included was limited to English and Spanish publications.
Despite the low prevalence of these diseases, the increased recognition of radiological patterns, pathological features, and diagnostic procedures, have permitted their better characterization. This review highlights epidemiology, clinical presentation, diagnosis, natural history, and treatment.
Lesser-studied ILD represent a diagnostic and therapeutic challenge and can be frequently misdiagnosed. Also, due to the lack of randomized controlled trials, there are no well-established therapeutic options. Further studies or registries are needed to improve accurate diagnosis and management.
间质性肺疾病(ILDs)包含200多种类型。其中,纤维化性肺疾病由于出现了针对其治疗的新疗法,最近引起了特别关注。然而,加深我们对其他不太常见的ILD的了解很重要,因为它们中的许多与不良预后相关。本叙述性综述旨在对一些认识不足的ILD提供实用且最新的描述。它涵盖罕见的特发性间质性肺炎及其组织学模式、伴有间质性肺受累的遗传性疾病(Hermansky-Pudlak综合征),以及与肺淋巴组织良性增生相关的ILD,即滤泡性细支气管炎和肉芽肿性淋巴细胞间质性肺病。
使用特定关键词对PubMed和谷歌学术进行电子检索。对文章进行相关性筛选,涵盖综述文章、荟萃分析、系统评价、病例系列、前瞻性研究、学会指南、同行评审期刊的社论;关于该主题的科学书籍。纳入的数据仅限于英文和西班牙文出版物。
尽管这些疾病的患病率较低,但对放射学模式、病理特征和诊断程序的认识增加,使得对它们有了更好的特征描述。本综述重点介绍了流行病学、临床表现、诊断、自然史和治疗。
研究较少的ILD代表着诊断和治疗挑战,且经常被误诊。此外,由于缺乏随机对照试验,尚无成熟的治疗方案。需要进一步的研究或登记来改善准确的诊断和管理。